106 Results for "

cd73

" in MedChemExpress (MCE) Product Catalog:
Products (106)

106 Results for "cd73" in MCE Product Catalog:

Cat. No.: HY-169189
CAS No.: 3037968-61-6
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73). CD73-IN-18 can be used in anti-cancer research .
loading...
    loading...
Cat. No.: HY-P991612
Synonyms: Sym024

Target:  

CD73

Research Areas:  

Inflammation/Immunology Cancer

S095024 is a humanized IgG1 monoclonal antibody inhibitor targeting CD73. S095024 can be used to study acute respiratory distress syndrome (ARDS), non-small cell lung cancer (NSCLC) and advanced solid tumor malignancies .
loading...
    loading...
Cat. No.: HY-170525
CAS No.: 333329-22-9
Target:  

CD73

Research Areas:  

Inflammation/Immunology

CD73-IN-19 (Compound 4ab) is a CD73 inhibitor (with a 44% inhibition rate of CD73 enzymatic activity at 100 μM). CD73-IN-19 (at 10 μM and 100 μM) can completely antagonize the blockade of T cell proliferation induced by TCR (T cell receptor) triggering (which is induced by CD73 activity), and it can also inhibit the hA2A receptor activity in HEK-293 cells (Ki is 3.31 μM). CD73-IN-19 holds promise for research in the field of immune diseases .
loading...
    loading...
Cat. No.: HY-P991634
IBI-325 is a humanized monoclonal antibody inhibitor targeting CD73. IBI-325 completely inhibits CD73 enzymatic activity without hook effect. IBI-325 reverses Adenosine monophosphate (HY-A0181)-mediated immune suppression and significantly inhibits T cell proliferation and cytokines (IL-2, IFN-γ and TNF-α) release. IBI-325 has potent antitumor activities in hPBMC-reconstituted mice model and hCD73 knock-in mice model. IBI-325 can be used for cancer immunotherapy research .
loading...
    loading...
Cat. No.: HY-152074
CAS No.: 2407356-67-4
Target:  

CD73

Research Areas:  

Cancer

D73-IN-14 is a potent, selective and orally active CD73 inhibitor with an IC50 value of 0.17 nM. CD73-IN-14 increases the number of tumor-infiltrating CD8 + cells and shows anti-tumor activity . CD73-IN-14 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-137682A
Synonyms: GpCp trisodium
Target:  

CD73

Research Areas:  

Cancer

GMPCP (GpCp) trisodium (Compound 7 trisodium) is a guanosine derivative is a CD73 inhibitor, with Kis of 1110 nM (rat soluble CD73) and 410 nM (human soluble CD73) respectively. GMPCP (GpCp) trisodium can be used for research of cancer .
loading...
    loading...
Cat. No.: HY-162917
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-16 (compound 18) is an inhibitor of hCD73 with IC50 values of 0.28 μM .
loading...
    loading...
Cat. No.: HY-161677
CAS No.: 3048634-84-7
Target:  

PD-1/PD-L1 CD73

Research Areas:  

Inflammation/Immunology Cancer

PD-L1/CD-73-IN-1 (compound CC-5) is PD-L1/CD73 inhibitor with IC50 values of 6 nM and 0.773 μM to PD-L1 and CD73, respectively. PD-L1/CD-73-IN-1 inhibits tumor cell growth in vivo and in vitro .
loading...
    loading...
Cat. No.: HY-P991332

Target:  

CD73

Research Areas:  

Cancer

JAB-BX102 is a human monoclonal antibody (mAb) targeting NT5E/CD73. JAB-BX102 can be used in the study of cancers such as breast cancer, pancreatic cancer, and prostate cancer .
loading...
    loading...
Cat. No.: HY-125286A
Target:  

CD73

Research Areas:  

Cancer

AB-680 ammonium is a highly potent, reversible and selective inhibitor of CD73 (an ecto-nucleotidase), with a Ki of 4.9 pM for hCD73, displays >10,000-fold selectivity over related ecto-nucleotidases CD39. Anti-tumor activity .
loading...
    loading...
Cat. No.: HY-172801
Target:  

CD73

Research Areas:  

Cancer

PSB-24000 (Compound 27) is a selective ecto-5'-nucleotidase (CD73) inhibitor with a Ki value of 563 nM against human CD73 (Ki= 481 nM at membrane-bound CD73 in triple-negative breast cancer cells). PSB-24000 interferes with CD73's recognition and action on the substrate AMP, and prevents the generation of immunosuppressive and cancer-promoting adenosine from AMP. PSB-24000 is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-150048
CAS No.: 2204291-78-9
Target:  

CD73 Apoptosis

Research Areas:  

Cancer

BK50164 is a potent CD73 inhibitor with an IC50 value of 13.089 μM. BK50164 binds to CD99 with a KD value of 1.5 μM. BK50164 shows antiproliferative activity. BK50164 induced Apoptosis and cell cycle arrest at Sub-G1 phase .
loading...
    loading...
Cat. No.: HY-137717A
Target:  

CD73

Research Areas:  

Cancer

COPCP trisodium (Compound 7a) is a potent and selective ecto-5'-nucleotidase CD73 inhibitor. COPCP trisodium blocks CD73-mediated adenosine production, reducing the inhibitory effect of adenosine on immune cells. COPCP trisodium is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-W095633
CAS No.: 89-02-1
Target:  

CD73

Research Areas:  

Cancer

2,4-Dinitrobenzenesulfonic acid (Compound 3) is a ecto-5'-Nucleotidase (CD73) inhibitor with a Ki value of 63 μM for human and 144 μM for rat. 2,4-Dinitrobenzenesulfonic acid can inhibit the hydrolysis of adenosine monophosphate (AMP) to generate adenosine. 2,4-Dinitrobenzenesulfonic acid can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-181919
Research Areas:  

Cancer

CD73-IN-22 (Compound HX-6) is a non-nucleoside CD73 inhibitor with an IC50 of 0.07 μM. When radiolabeled with 68Ga, CD73-IN-22 acts as a PET radiotracer for detecting CD73 expression. When radiolabeled with 177Lu, CD73-IN-22 exhibits anticancer activity against colorectal adenocarcinoma. CD73-IN-22 is applicable to research related to colon adenocarcinoma and breast cancer .
loading...
    loading...
Cat. No.: HY-136978A
Purity:  99.87%
Target:  

CD73

Research Areas:  

Inflammation/Immunology Cancer

OP-5244 sodium is a potent and orally active inhibitor of CD73, with an IC50 of 0.25 nM. OP-5244 sodium reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research .
loading...
    loading...
Cat. No.: HY-183701
Target:  

NTPDase CD73

Research Areas:  

Inflammation/Immunology Cancer

CD73/NTPDase1-IN-1 is a dual NTPDase1 and CD73 inhibitor, with IC50 values of 2.20 μM and 1.70 μM against human targets, respectively. CD73/NTPDase1-IN-1 can be used in the research of diseases such as inflammation, immunity and tumors .
loading...
    loading...
Cat. No.: HY-103695R
CAS No.: 2132396-40-6
Research Areas:  

Cancer

CD73-IN-1 (Standard) is the analytical standard of CD73-IN-1 (HY-103695). This product is intended for research and analytical applications. CD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.
loading...
    loading...
Cat. No.: HY-171805
CAS No.: 1213268-73-5
Target:  

CD73

Research Areas:  

Cancer

PSB-0963 is a selective and competitive ecto-5'-nucleotidase (eN/CD73) inhibitor with a Ki of 150 nM for rat ecto-5'-nucleotidase. PSB-0963 shows high selectivity over other ectonucleotidases (NTPDases 1-3) and P2Y receptors. PSB-0963 can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-144072
CAS No.: 2411665-73-9
Target:  

CD73

Research Areas:  

Inflammation/Immunology Cancer

MRS4620 is a potent CD73 inhibitor, with a Ki of 0.436 nM. MRS4620 can be use for the research of cancer immunoresearch .
loading...
    loading...